Tofacitinib and Malignancy Risk: Dr. Seoyoung Kim Save Nov 10, 2021 9:09 am Dr. David Liew interviews Dr. Seoyoung Kim at the ACR21 annual meeting. ADD THE FIRST COMMENT If you are a health practitioner, you may Login/Register to comment.Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.